Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid
- PMID: 202652
Correlation between the ability of tumor cells to resist humoral immune attack and their ability to synthesize lipid
Abstract
Agents that increase (certain metabolic inhibitors, chemotherapeutic agents, and x-irradiation), decrease (hormones), or have no effect (hyperthermia) on the susceptibility of line-1 and line-10 guinea pig hepatoma cells to humoral immune attack were studied for their effects on the ability of these tumor cells to synthesize macromolecules. A correlation was found between the drug-induced increase in sensitivity of these cells to antibody-C mediated killing and the loss of their ability to incorporate fatty acids into complex cellular lipids. Similarly, the hormone-induced increase in resistance of the cells to killing was accompanied by an enhancement in complex lipid synthesis by these cells was also observed after the cells were exposed to physical means of insult (x-irradiation or hyperthermia). No correlation was found between the sensitivity of the cells to antibody-C mediated killing and their ability to synthesize DNA, RNA, protein, or complex carbohydrate, or their capacity for de novo lipid synthesis as measured by incorporation of acetate and glycerol into cellular macromolecules. The assembly of free fatty acids into complex lipid moieties is therefore proposed to be of fundamental importance for the ability of the tumor cells to resist humoral immune killing.
Similar articles
-
Identification of lipids associated with the ability of tumor cells to resist humoral immune attack.J Immunol. 1978 Feb;120(2):472-80. J Immunol. 1978. PMID: 202653
-
Effect of inhibiting DNA, RNA, and protein synthesis of tumor cells on their susceptibility to killing by antibody and complement.Cancer Res. 1977 May;37(5):1432-7. Cancer Res. 1977. PMID: 192450
-
Correlation between the ability of tumor cells to incorporate specific fatty acids and their sensitivity to killing by a specific antibody plus guinea pig complement.J Natl Cancer Inst. 1978 Sep;61(3):931-4. J Natl Cancer Inst. 1978. PMID: 278869
-
Humoral immune killing of nucleated cells: mechanisms of complement-mediated attack and target cell defense.Crit Rev Immunol. 1981 Jan;1(3):165-209. Crit Rev Immunol. 1981. PMID: 6174273 Review.
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
Cited by
-
Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects.Biochem J. 1989 Nov 15;264(1):1-14. doi: 10.1042/bj2640001. Biochem J. 1989. PMID: 2690818 Free PMC article. Review. No abstract available.
-
Pancreatic B cells possess defense mechanisms against cell-specific toxicity.Proc Natl Acad Sci U S A. 1986 Jul;83(14):5267-71. doi: 10.1073/pnas.83.14.5267. Proc Natl Acad Sci U S A. 1986. PMID: 2941762 Free PMC article.
-
Sublytic complement protects prostate cancer cells from tumour necrosis factor-α-induced cell death.Clin Exp Immunol. 2012 Aug;169(2):100-8. doi: 10.1111/j.1365-2249.2012.04596.x. Clin Exp Immunol. 2012. PMID: 22774984 Free PMC article.
-
Integration of a virus membrane protein into the lipid bilayer of target cells as a prerequisite for immune cytolysis. Specific cytolysis after virosome-target cell fusion.J Exp Med. 1979 Dec 1;150(6):1383-98. doi: 10.1084/jem.150.6.1383. J Exp Med. 1979. PMID: 512589 Free PMC article.
-
Tumour immunology: a review.J R Soc Med. 1984 Dec;77(12):1023-9. doi: 10.1177/014107688407701207. J R Soc Med. 1984. PMID: 6439868 Free PMC article. Review. No abstract available.